FibroGen Stock Target Price and Analyst Consensus

FGEN Stock  USD 0.41  0.01  2.38%   
The current analyst and expert consensus on FibroGen is Hold, with no strong buy opinions. The current projected FibroGen target price consensus is 2.17 with 2 analyst opinions. Check out Macroaxis Advice on FibroGen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
The most common way FibroGen analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview FibroGen executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on FibroGen. We encourage you to use your own analysis of FibroGen to validate this buy or sell advice. FibroGen buy-or-sell recommendation module provides average expert sentiment on the projected FibroGen target price to derive its highest and lowest estimates based on projected price volatility of 5.8086.
Lowest Forecast
1.97
Highest Forecast
2.41
Target Price
2.17
At this time, FibroGen's Gross Profit is very stable compared to the past year. As of the 4th of December 2024, Gross Profit Margin is likely to grow to 0.92, though Pretax Profit Margin is likely to grow to (1.84). At this time, FibroGen's Short Term Investments are very stable compared to the past year. As of the 4th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 665.2 M, while Short and Long Term Debt Total is likely to drop about 89.2 M.
  
It's important to approach FibroGen's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize FibroGen price targets

FibroGen's stock target price is an estimate of its future price, usually made by analysts. Using FibroGen's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at FibroGen's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if FibroGen's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional FibroGen Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of FibroGen is a key component of FibroGen valuation and have some predictive power on the future returns of a FibroGen.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of FibroGen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.426.29
Details
Intrinsic
Valuation
LowRealHigh
0.040.846.71
Details
Naive
Forecast
LowNextHigh
0.010.446.32
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.21-0.21-0.21
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Online Gaming Idea
Online Gaming
Invested few shares
Tech Growth Idea
Tech Growth
Invested one share
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Size And Style ETFs Idea
Size And Style ETFs
Invested few shares
Alternative Energy Idea
Alternative Energy
Invested over 20 shares
Millennials Best Idea
Millennials Best
Invested one share
Momentum Idea
Momentum
Invested few shares
Rentals Idea
Rentals
Invested one share
Impulse Idea
Impulse
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 200 shares
When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock:
Check out Macroaxis Advice on FibroGen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.